VEGFA and type 2 diabetes mellitus: Increased inflammation is a risk factor for atherosclerotic peripheral vascular disease in type II Diabetes mellitus patients, and this was supported by the observation that these patients have increased EVs containing inflammatory proteins, such as CD5 and higher VEGF-A levels compared to euglycemic controls [161].